drugset / Trial / NCT00285142

Effect of Rosiglitazone

NCT00285142

Completed 12 enrolled University Hospital, Montpellier
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate : * acute effects of a single dose of 8 mg rosiglitazone (therapeutic dose) * on insulin secretion and * insulin sensitivity in 12 healthy male subjects.

Timeline

Start
2004-06
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 8 mg Oral

Indications

No indication recorded.